Karachi: IBL Healthcare Limited convened its annual general meeting on October 27, 2026, where shareholders approved key resolutions that will shape the company's financial and operational landscape in the coming year. The meeting, attended both physically and through a video link, underscored the company's commitment to transparency and shareholder engagement.

The resolutions passed included the approval of the minutes from the Extraordinary General Meeting held on August 12, 2026. Shareholders also adopted the audited financial statements for the fiscal year ending June 30, 2026, along with the Director's and independent auditors' reports. This adoption marks a significant step in maintaining financial accountability and regulatory compliance.

Further, the appointment of A.F. Ferguson & Co. as auditors was confirmed. The firm will serve from the conclusion of this meeting until the next annual general meeting, with remuneration to be determined by the company's directors. This decision ensures continuity and stability in the company's auditing processes.

In terms of special business, the transactions with related parties, as disclosed in note 35 of the financial statements, were ratified, approved, and confirmed by the shareholders. The board was also authorized to approve related party transactions on a case-by-case basis until the next AGM. These transactions will be subject to shareholder ratification at the subsequent annual meeting.

The resolutions reflect IBL Healthcare Limited’s proactive stance in financial governance and strategic planning. According to information available from the Pakistan Stock Exchange (PSX), these measures are critical for maintaining investor confidence and ensuring the company's long-term sustainability in the designated market category.